Martin “Pharma Bro” Shkreli earned national attention in September 2015 when a company he founded earlier the same year, Turing Pharmaceuticals, acquired the drug Daraprim and raised its price from $13.50 to $750 per tablet. That’s an astronomical increase of 5,000%. However, a fraudulent scheme involving three other companies he founded is what landed him …